Amgen Inc. (NASDAQ: AMGN) has reported lower revenues and adjusted earnings for the first quarter of 2023. The biotechnology firm also provided
AMGN Earnings: Everything you need to know about Amgen’s Q1 results
Categories
Health Care
Gilead Sciences (GILD) Earnings: 1Q23 Key Numbers
Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.4 billion for the first quarter of 2023, which was down 4% year-over-year.
Eli Lilly and Company (LLY) Q1 2023 Earnings Call Transcript
Eli Lilly and Company (NYSE: LLY) Q1 2023 earnings call dated Apr. 27, 2023 Corporate Participants: Joe Fletcher -- Senior Vice President of Investor
Bristol-Myers Squibb (BMY) reports higher Q1 profit; revenue down 3%
Biotechnology company Bristol Myers Squibb (NYSE: BMY) said its first-quarter adjusted earnings increased modestly, despite a decline in revenues. Net income attributable
MRK Earnings: Highlights of Merck’s Q1 2023 financial results
Pharma firm Merck & Co., Inc. (NYSE: MRK) on Thursday reported lower earnings for the first quarter of 2023, due to a sharp
Earnings: Highlights of Eli Lilly & Company’s (LLY) Q1 2023 results
Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The company also
Amgen Inc. (AMGN) Q1 2023 Earnings Call Transcript
Amgen Inc. (NASDAQ: AMGN) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Arvind Sood — Vice President, Investor Relations Robert A. Bradway — Chairman
Ocean Biomedical reports new results validating tumor suppression with anti-Chi3L1 antibody: EF Hutton raises OCEA price target to $17
Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said its scientific co-founder Jack Elias published new findings in Cancer Research, a peer-reviewed
Merck & Co., Inc. (MRK) Q1 2023 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Robert
ABBV Infographic: AbbVie’s Q1 2023 earnings and revenue decline
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a decrease in first-quarter 2023 adjusted earnings and revenues. The company also provided guidance for
Eli Lilly and Company (LLY) Q1 2023 Earnings Call Transcript
Eli Lilly and Company (NYSE: LLY) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Joe Fletcher -- Senior Vice President
AbbVie (ABBV) Q1 2023 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Elizabeth Shea -- Senior Vice President of Investor Relations
Quest Diagnostics Inc (DGX) Q1 2023 Earnings Call Transcript
Quest Diagnostics Inc (NYSE: DGX) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Shawn Bevec -- VP, Investor Relations James E. Davis -- Chairman,
Edwards Lifesciences Corporation (EW) Q1 2023 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE: EW) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Mark Wilterding -- Senior Vice President, Investor Relations and
BioMarin Pharmaceutical Inc (BMRN) Q1 2023 Earnings Call Transcript
BioMarin Pharmaceutical Inc (NASDAQ: BMRN) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Traci McCarty -- Group Vice President, Investor Relations Jean-Jacques
Thermo Fisher Scientific Inc (TMO) Q1 2023 Earnings Call Transcript
Thermo Fisher Scientific Inc (NYSE: TMO) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Rafael Tejada -- Vice President Investor Relations Marc
Humana Inc (HUM) Q1 2023 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Lisa Stoner -- Vice President, Investor Relations Bruce D. Broussard -- President
Boston Scientific Corp (BSX) Q1 2023 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
BSX Earnings: Highlights of Boston Scientific’s Q1 2023 results
Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the first quarter of 2023. The company also provided guidance for
Infographic: How Thermo Fisher Scientific (TMO) performed in Q1 2023
Thermo Fisher Scientific Inc. (NYSE: TMO) reported first quarter 2023 earnings results today. Revenue was $10.71 billion, down 9% from the same
Novartis AG (NVS) Q1 2023 Earnings Call Transcript
Novartis AG (NYSE:NVS) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant Narasimhan — Chief Executive